undefined undefined undefined

Company

undefined

about us

Bioextrax is an innovation-based company focused on the development and commercialisation of a unique bio-extraction platform technology. The company was founded in 2014 as a spin-off company from the Department of Biotechnology at Lund University in Sweden.

PHA

undefined

Bioextrax has developed, tested and verified a potent microbial strain that can extract a variety of pure bio-plastic (PHA) granules from different PHA-producing bacteria. This microbial strain allows for a more cost efficient and environmentally friendly PHA extraction process, also producing a valuable protein hydrolysate by-product. 

PHA

R&D

undefined

Bioextrax is committed to explore new applications of its bio-extraction platform technology through a comprehensive R&D program. This will allow the company to enter new markets in the coming years, fully leveraging the potential of its platform technology in the production of bio-based plastics, chemicals, oils and nutritional supplements.

R&D

Technology

undefined

Bioextrax technology is based on the selective lysis of microbial cell walls under mild conditions using a novel proprietary microbial isolate. This microbial isolate has multiple applications, many of which Bioextrax will explore in the coming years. For PHA producers, the technology provides for a cost efficient and effective extraction technology, producing PHA resins of a high purity, integrity and recovery.

The global market for biodegradable polyhydroxyalkanoate (PHA) bio-plastic is still in the order of several hundred million US dollars, dominated by roughly 10 PHA producers. The potential market for PHA bio-plastics is however many times larger than this, as these bio-plastics have both the properties and potential to replace most polyethylene (PE) and polypropylene (PP) plastics, a market worth over 450 billion USD.

Bioextrax novel bio-extraction technology is patent pending. It is the intention of the company to build a strong patent portfolio leveraging its current microbial strain, as well as identify and verify new strains and/or enzymes through its research and development activities. This IP portfolio will ensure that Bioextrax remains a leader in offering cost efficient and environmentally friendly bio-extraction technologies.

Investors

undefined

Bioextrax is a privately owned company focused on the development and commercialisation of a unique bio-extraction platform technology.

If you are interested to become an investor in Bioextrax, please feel free to contact us below.

Media

undefined

2015-11-23
Bioextrax selected as awards finalist
Read more

2015-11-03
Bioextrax moves into LSI
Read more

2015-06-11
Bioextrax awarded Vinnova grant
Read more

Contact

undefined

Call us at:

+46 (0)40 6170999

E-mail us at:

info [at] bioextrax.com

Visit or mail us at:

Bioextrax AB
Medicon Village,
223 81 Lund, Sweden